Home » ICH Addresses Risk of Unintended Germline Transmissions in Gene Therapy
ICH Addresses Risk of Unintended Germline Transmissions in Gene Therapy
November 15, 2006
The International Conference on Harmonization (ICH)s Gene Therapy Discussion Group last month finalized a document that outlines general considerations for investigating and addressing risks of inadvertent germline integration during the development of gene therapy products.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor